Efter omhyggelig vurdering af nyttevirkning/ risiko skal der tages en beslutning om enten at afbryde amningen eller behandlingen med Mimpara.
Following careful benefit/ risk assessment, a decision should be made to discontinue either breast-feeding or treatment with Mimpara.